about
Nutrition recommendations and interventions for diabetes--2006: a position statement of the American Diabetes AssociationBody mass index and physical function in older women.The causes, prevalence, and treatment of obesity revisited in 2009: what have we learned so far?Overnight dexamethasone suppression test: a reliable screen for Cushing's syndrome in the obese.Effect of medical and surgical weight loss on endothelial vasomotor function in obese patients.Best practice guidelines in pediatric/adolescent weight loss surgery.Obesity prevalence from a European perspective: a systematic reviewWeight loss surgery eligibility according to various BMI criteria among adolescents.The endocrinopathies of anorexia nervosa.Best practice updates for multidisciplinary care in weight loss surgeryOverweight in older children and adolescents: treatment or prevention?Maladaptive enlargement of the brachial artery in severe obesity is reversed with weight lossEffects of exenatide combined with lifestyle modification in patients with type 2 diabetes.Preoperative weight gain might increase risk of gastric bypass surgery.Board certification and credentialing in nutrition.Long-term successful weight loss improves vascular endothelial function in severely obese individuals.Obesity and cardiovascular diseaseB lymphocytes in human subcutaneous adipose crown-like structuresEmerging pharmacotherapy for obesity.Obesity begets atrial fibrillation: a contemporary summaryDrug-induced weight gain.Diet modification for treatment and prevention of obesity.A randomized, phase 3 trial of naltrexone SR/bupropion SR on weight and obesity-related risk factors (COR-II)Hunger strikes, force-feeding, and physicians' responsibilities.Decreased AMP-activated protein kinase activity is associated with increased inflammation in visceral adipose tissue and with whole-body insulin resistance in morbidly obese humans.Executive summary of the recommendations of the American Association of Clinical Endocrinologists, the Obesity Society, and American Society for Metabolic & Bariatric Surgery medical guidelines for clinical practice for the perioperative nutritionalZonisamide for weight reduction in obese adults.Elevated proinflammatory cytokine production by a skewed T cell compartment requires monocytes and promotes inflammation in type 2 diabetes.Reduced adipose tissue inflammation represents an intermediate cardiometabolic phenotype in obesity.Self-monitoring of blood glucose with finger tip versus alternative site sampling: effect on glycemic control in insulin-using patients with type 2 diabetes.Management of diabetes across the course of disease: minimizing obesity-associated complicationsOverweight and obesity predict time to periodontal disease progression in men.Arteriolar function in visceral adipose tissue is impaired in human obesityThe relationship of ectopic lipid accumulation to cardiac and vascular function in obesity and metabolic syndrome.Inducible Toll-like receptor and NF-kappaB regulatory pathway expression in human adipose tissueMetabolic support of the obese intensive care unit patient: a current perspectiveInsulin sensitive and resistant obesity in humans: AMPK activity, oxidative stress, and depot-specific changes in gene expression in adipose tissue.Expectations for weight loss and willingness to accept risk among patients seeking weight loss surgery.Aggressive diets and lipid responses.Relation of depot-specific adipose inflammation to insulin resistance in human obesity.
P50
Q28260334-DF550C37-E9A4-4763-9E2F-7F099EEB2144Q30843229-9BAACA40-C2F0-4B5C-82F0-E871FF9B2AAFQ30882264-F9244F8C-21E5-465F-89C0-7ECA70E06FCCQ31121920-23710EFB-EF46-4DDA-971C-D57C98103826Q31140445-4687AEFA-3C1B-45D9-AFED-B54764B4ED38Q33213378-3CA94919-A0E6-4CBD-A616-EB30829FD68DQ33340814-C499A0E8-EE02-4B45-849C-E519F5DC2268Q33384408-906ECA20-77E6-455C-9BD8-CF2EACB4B76AQ33394509-57DC85C7-1F1C-4980-998E-71F137B20B90Q33435245-F4547B01-9927-44D6-BD1A-8563E3C8CF59Q33521163-0E3AA201-4FC8-4E17-9AF9-A15A68FFD7DFQ33550665-18250158-39F2-41DA-AFD5-A86E8A556F1EQ33558150-076F1EDE-D23B-45EC-BC27-193DC740655FQ33757051-F89B9F06-1277-44FD-A20F-7FA8BE582806Q33768441-477689E6-C9D6-4D20-841C-751FCA9D498CQ33803736-F1ABC821-DCC3-486A-AAD3-A10EA898F5D5Q34185483-F47C9902-EDF5-48A4-B615-96A9D132D4EBQ34186722-06F6ECD3-472E-4577-9AF0-571E62E5B972Q34207458-BEB653C1-F38F-4F6F-BC8E-8EF95CCC5431Q34359251-BAE32115-8182-46F4-BD2C-7C2FE3B0BC31Q34460868-432B3B27-3E6D-4540-BB58-58AF28EA8862Q34514784-B658A88D-47F1-442C-B660-A1F4079A2EC9Q34585609-04273CE5-B802-4C9A-97BB-BD7CF5FCC048Q34658083-B9F1FD5B-FE09-4C15-B07A-462A6F5DFBF6Q34703328-73F003A0-B793-4858-810F-B94F2E96E39EQ34776855-AD0C650A-3BD4-46F1-BE05-3B346E117992Q34940173-CC37E67D-FB1B-4704-8A66-488BB7964C6AQ34950622-E2A441BC-7AC2-45C1-BBA8-D4B52DE0CE49Q35094008-F7D98C5C-7018-4055-A09F-F6233859C2EBQ35377743-DB394AF2-F0DE-46E6-A507-821F9C201B61Q35574560-832B524D-C873-4E88-BAD0-107B0607F13FQ35672750-48F3BC19-1984-43C1-AEA5-572D9B7E82B7Q35683298-39E679E2-0358-46EB-B3B1-97FDF3F6C2C3Q35688755-F7F9365E-E3BF-46E0-A581-C4BDAA0FB86BQ35688789-2767ECE2-9F08-49D0-8553-45515D70BD5BQ35755204-12ECA31E-1F4E-49D2-A4E9-B539524E1E5AQ35839705-9F6F364B-E42C-4522-AD4A-6C7C405D686AQ35878310-B29A12EA-1BB4-4A51-9754-5222C4AF2E54Q35918852-62A5D9E0-28BF-48F1-9D34-CEDEC98D94DAQ35926642-8465DC44-73D4-4213-9F8F-C88B7EFB523A
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Caroline M Apovian
@ast
Caroline M Apovian
@en
Caroline M Apovian
@es
Caroline M Apovian
@nl
Caroline M Apovian
@sl
type
label
Caroline M Apovian
@ast
Caroline M Apovian
@en
Caroline M Apovian
@es
Caroline M Apovian
@nl
Caroline M Apovian
@sl
prefLabel
Caroline M Apovian
@ast
Caroline M Apovian
@en
Caroline M Apovian
@es
Caroline M Apovian
@nl
Caroline M Apovian
@sl
P106
P21
P31
P496
0000-0002-8029-1922